CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Transcatheter Interventions for Tricuspid Valve Disease: What to Do and Who to Do it On Dual Antiplatelet TherapyIs It Time to Cut the Cord With Aspirin? Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial Diagnostic accuracy of fractional flow reserve from anatomic CT angiography Mitral Valve Remodeling and Strain in Secondary Mitral Regurgitation: Comparison With Primary Regurgitation and Normal Valves Guideline‐Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient‐Pooled Analysis From the KorHF and KorAHF Registries 2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure A Report of the American College of Cardiology Solution Set Oversight Committee 2-Year Outcomes After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients

Review Article2021 Jan 22;S0828-282X(21)00056-8.

JOURNAL:Can J Cardiol. Article Link

Transcatheter Interventions for Tricuspid Valve Disease: What to Do and Who to Do it On

G Muntané-Carol, A Alperi, J Rodés-Cabau et al. Keywords: tricuspid valve disease; tricuspid regurgitation; end-stage right ventricular heart failure;

Full Text PDF